MVP 1.23% 40.0¢ medical developments international limited

Another Positive Study, page-35

  1. 4,370 Posts.
    lightbulb Created with Sketch. 1533
    Methoxyflurane Study Ending and Beginning Again
    https://www.rppeo.ca/clinical-development/medicnews/1497-medicnews-for-october-2021.html
    https://sway.office.com/VvHbwdqzUE3EXFEk?ref=Link

    The methoxyflurane feasibility study has got almost enough patient data to call it done. In their recent newsletter to Hasting Quinte paramedics participating in the study, RPPEO researchers let them know that another study is planned in the region:

    "The next study will train about 700 paramedics (ACPs and PCPs) from different services to use methoxyflurane. The 8 paramedic services that have agreed to participate are Hastings Quinte, Frontenac, Leeds Grenville, Lennox & Addington, Cornwall, Lanark, Prescott Russell and Renfrew. Once we secure funding, we will randomize the services into clusters. The study will begin with all services capturing data on patients who meet the inclusion criteria and then we will introduce methoxyflurane into the services one at a time in a step design over an 9-month period."

    The research team hopes to begin the next study in the New Year 2022.
    Last edited by jcurve: 23/10/21
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.005(1.23%)
Mkt cap ! $45.06M
Open High Low Value Volume
40.5¢ 41.8¢ 40.0¢ $3.462K 8.436K

Buyers (Bids)

No. Vol. Price($)
5 54712 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 15563 4
View Market Depth
Last trade - 16.10pm 27/12/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.